4892

譬ｪ蠑丈ｼ夂､ｾ繧ｵ繧､繝輔Η繝ｼ繧ｺ

株式会社サイフューズ
Pharmaceutical
Cyfuse Biomedical K.K. develops, manufactures, and sells regenerative medicine-related products in Japan, Europe, and the United States. The company offers the Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bone, blood vessels, and nerves; regenova, a 3D software that creates 3D data where spheroids shall be mounted; and S-PIKE that develops 3D-structures from cells. It also provides the Human 3D Mini-Liver, an in vitro MASH model that recapitulates human liver functions and predicts efficacy of drugs. Cyfuse Biomedical K.K. was incorporated in 2010 and is headquartered in Minato, Japan.
← Companies
Price
¥590
Market Cap
¥5.7B
Ent. Value
¥3.3B
Net Cash
¥2.4B
Shares Out.
9.6M
P / E
—
EV / EBIT
—
P / Book
2.13×
P / NCAV
2.34×
Div. Yield
—
Financials
Metric FY 2025
EDINET ↗ 		FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗
Net Sales ¥231M ¥54M ¥61M ¥374M
Cost of Sales ¥117M ¥38M ¥23M ¥133M
Gross Profit ¥114M ¥17M ¥38M ¥241M
SG&A ¥942M ¥913M ¥735M ¥667M
Operating Income ¥-828M ¥-896M ¥-697M ¥-425M
Non-Operating Income ¥109M ¥47M ¥132M ¥48M
Interest Income ¥4M ¥0M ¥0M ¥0M
Non-Operating Expenses ¥42M ¥20M ¥21M ¥56M
Interest Expense ¥14M ¥10M ¥10M ¥7M
Ordinary Income ¥-761M ¥-870M ¥-586M ¥-433M
Pre-tax Income ¥-761M ¥-870M ¥-586M ¥-472M
Income Taxes ¥3M ¥2M ¥3M ¥2M
Current Tax ¥3M ¥2M ¥3M ¥2M
Net Income (owners) ¥-764M ¥-872M ¥-589M ¥-474M
EBITDA ¥-793M ¥-860M ¥-659M ¥-371M
EPS ¥-86.78 ¥-108.34 ¥-75.42 ¥-177.67
Shares Outstanding 9.6M 8.2M 7.9M 7.8M
Shares Issued (total) 9.6M 8.2M 7.9M 7.8M